Aktien Sensor

Universal Health Services Inc reported strong second-quarter financial results, exceeding Wall Street estimates for profit and revenue.

Stryker Corp has launched the InThrill Thrombectomy System, a medical technology designed to improve thrombectomy procedures and address small vessel thrombus cases.

Sysmex Corp, a Japanese healthcare equipment company, is well-positioned to benefit from the growing demand for molecular diagnostics, despite a recent decline in its stock price.

Becton Dickinson & Co. has secured FDA clearance for its BD Veritor System for SARS-CoV-2, a digital COVID-19 test that delivers rapid results in 15 minutes.

Sigma Healthcare’s revenue growth is a mixed bag for investors, with a complex valuation landscape and negative price-to-earnings ratio raising concerns about earnings justification.

DiaSorin SpA is well-positioned to benefit from the growing demand for molecular diagnostics, driven by advances in genomic technologies and increasing disease prevalence.

Coloplast A-S stock price has been fluctuating amid industry trends, with competitors also experiencing market movements and a cautious overall market sentiment prevailing.

Alcon AG, a Swiss healthcare company, has seen its stock price increase significantly over the past few years, with a 30% gain for investors who purchased the stock five years ago.

Labcorp has achieved a major milestone in personalized cancer care by securing IVDR CE-marking for its PGDx elio tissue complete test in the EU, expanding access to advanced cancer care and launching a new initiative to increase marrow donors.

GE Healthcare Technologies Inc. has seen significant trading activity in its stock, which is expected to benefit from the growing trend of AI development in the healthcare sector.